z-logo
open-access-imgOpen Access
An observational study to evaluate the efficacy Pachana Poorvaka Shodhana i.e. Agnilepa Chikitsa followed by Virechana Karma in the management of Amavata w.s.r. to Rheumatoid Arthritis
Author(s) -
T Deepanjali,
Kiran M Goud,
Prerana Singhal
Publication year - 2019
Publication title -
journal of ayurveda and integrated medical sciences
Language(s) - English
Resource type - Journals
ISSN - 2456-3110
DOI - 10.21760/jaims.4.6.9
Subject(s) - medicine , rheumatoid arthritis , joint pain , physical therapy , dermatology
The change in life style, food habits have contributed to a number of new diseases which have becomea challenge for the human race, one among such diseases is Rheumatoid arthritis which is thecommonest joint disorder. It is a systemic inflammatory disease of undetermined aetiology involvingprimarily the synovial membrane and articular structures of multiple joint. The disease is oftenprogressive and result in pain, stiffness and swelling of joint. In India the prevalence rate is 0.1-0.4%.The symptoms of Rheumatoid arthritis are parallel with Amavata, as the name suggests Amavata iscomprise of two terms, Ama and Vata. The Nidanas such as Viruddhaahara, Viruddhacheshta,Mandagni, Nischalatva etc. due to consumption of Viruddahara and indulging in Viruddhacheshta theAma will be manifested. The manifested ama is carried by vata and circulates throughout the bodyand takes ashraya in Sandhis. Commonly affecting the joints of Hasta, Pada, Shira, Gulpha, Trika,Janu and Uru and characterized by pain similar to vrischika damshtra. In this present clinical trial, 10diagnosed patients of Amavata / Rheumatoid arthritis were selected randomly to evaluate the efficacyof Pachana Poorvaka Shodhana that is Agnilepa Chikitsa followed by Virechana Karma in Amavataw.s.r. to Rheumatoid Arthritis. Statistical analysis showed highly significant results p value (less than 0.0001)in almost all subjective and objective parameters of Amavata.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here